BeOne Medicines Ltd. (ONC) - Insider Holders & Insider Ownership

List of insiders holdings for BeOne Medicines Ltd.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1BAKER BROS. ADVISORS LP
14159 L.P.
Baker Bros. Advisors (GP) LLC
BAKER JULIAN
BAKER FELIX
667 L.P.
Baker Brothers Life Sciences LP
Director
10% Owner		2024-12-10 21:30:34125,276,610
0		125,276,610Form 13D
2HHLR ADVISORS LTD.
HILLHOUSE INVESTMENT MANAGEMENT LTD.
10% Owner		2025-05-13 16:15:1068,551,141
0		68,551,141Form 13D
3OYLER JOHN
Chief Executive Officer		2025-11-13 17:06:476,441,041
46,055,316		52,496,357Form 4
4CB Biotech Investment Ltd
CPEChina Fund L.P.
CITIC PE Associates L.P.
CITIC PE Funds Ltd
10% Owner		2016-02-09 20:07:3519,601,138
0		19,601,138Form 4
5AMGEN INC
10% Owner		2021-09-13 19:27:0718,943,802
0		18,943,802Form 4
6Wang Xiaodong
Chair, Scientific Advisory Brd		2025-11-12 16:47:024,582,601
4,978,213		9,560,814Form 4
7BAKER BROS. ADVISORS LP
667 L.P.
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Director		2025-05-22 16:10:0620,838
9,038,122		9,058,960Form 4
8Glazer Donald W.
Director		2024-06-07 16:58:012,752,615
0		2,752,615Form 4
9Li Ji
EVP and Gl. Head of Bus. Dev.		2018-03-02 18:41:222,721,000
0		2,721,000Form 4
10Peterson Amy C.
CMO, Immuno-oncology		2018-12-19 18:34:101,966,402
0		1,966,402Form 4
11Wang Lai
Global Head of R&D		2025-09-11 17:10:501,023,529
601,965		1,625,494Form 4
12Liang Howard
CFO & Chief Strategy Officer		2021-06-30 16:45:491,553,149
0		1,553,149Form 4
13Wu Xiaobin
President and COO		2025-11-14 17:35:301,033,226
4,000		1,037,226Form 4
14Yang Jianxin
Sr. VP, Head of Clinical Dev.		2016-07-15 16:34:25825,000
0		825,000Form 4
15Yan Wendy Xiaojun
Sr. VP, Head of Reg. Affairs		2016-07-15 16:30:50825,000
0		825,000Form 4
16Lee Chan Henry
SVP, General Counsel		2025-11-14 17:28:24485,953
0		485,953Form 4
17Wang Julia Aijun
Chief Financial Officer		2024-07-03 17:05:32426,595
0		426,595Form 4
18Huang Jane
CMO, Hematology		2021-12-16 17:50:15371,331
0		371,331Form 4
19Rosenberg Aaron
Chief Financial Officer		2025-08-05 17:16:07215,332
0		215,332Form 4
20Tang Ke
Director		2017-04-21 16:42:20199,992
0		199,992Form 4
21Yuan RuiRong
Chief Medical Officer		2016-02-09 20:08:35130,000
0		130,000Form 4
22Malley Thomas
Director		2023-06-20 19:00:29103,671
0		103,671Form 4
23HOOPER ANTHONY C
Director		2025-05-22 19:41:4387,490
0		87,490Form 4
24Dugan Margaret
Director		2025-05-22 19:44:0779,690
0		79,690Form 4
25Riva Alessandro
Director		2025-05-22 19:44:5579,690
0		79,690Form 4
26Ball Titus B.
Principal Accounting Officer		2025-09-04 17:29:5672,397
0		72,397Form 4
27Sanders Corazon (Corsee) D.
Director		2025-09-09 17:31:5457,226
0		57,226Form 4
28Yi Qingqing
Director		2025-06-12 16:19:0956,940
0		56,940Form 4
29BRANDICOURT OLIVIER
Director		2025-05-22 19:46:0250,076
0		50,076Form 4
30Sharp Shalini
Director		2025-05-22 19:47:0041,886
0		41,886Form 4
31su Jingshyh S
Director		2021-06-21 16:34:1225,298
0		25,298Form 4
32Chen Timothy Yung-Cheng
Director		2021-06-21 16:42:0825,298
0		25,298Form 4
33Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Research GmbH
10% Owner		2018-02-13 16:29:070
0		0Form 13G
34GOLLER MICHAEL
Director		2016-02-02 19:40:270
0		0Form 3
35KRISHANA RANJEEV
Director		2016-02-02 19:14:150
0		0Form 3